Dataset from Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies. Int J Nanomedicine. 2012;7:5793-806 (v.0)

This dataset includes data on the formulation of CB13-loaded nanoparticles, characterization results (size, zeta potential, and encapsulation efficiency), in vitro drug release profiles, cytotoxicity assays, and stability studies. This dataset provides detailed insights into how PLGA nanocarriers ca...

Descripción completa

Detalles Bibliográficos
Autores: Durán Lobato, María Matilde, Álvarez Fuentes, Josefa, Martín Banderas, Lucía, Prados Salazar, José Carlos, Melguizo Alonso, Consolación, Fernández Arévalo, María Mercedes, Holgado Villafuerte, María Ángeles
Tipo de recurso: conjunto de datos
Fecha de publicación:2024
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/166308
Acceso en línea:https://hdl.handle.net/11441/166308
https://doi.org/10.12795/11441/166308
Access Level:acceso abierto
Palabra clave:Dolor neuropático
CB13
Nanoprecipitación
Neuropathic pain
Nanoprecipitation
Descripción
Sumario:This dataset includes data on the formulation of CB13-loaded nanoparticles, characterization results (size, zeta potential, and encapsulation efficiency), in vitro drug release profiles, cytotoxicity assays, and stability studies. This dataset provides detailed insights into how PLGA nanocarriers can improve the oral bioavailability of hydrophobic drugs like CB13, with pharmacological potential in pathologies such as neuropathic pain.

Similares en LA Referencia